Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • Platinum Patios and Pavers is Expanding Its Operations by Opening a Branch in Indianapolis
    Platinum Patios and Pavers is Expanding Its Operations by Opening a Branch in Indianapolis Business
  • Proactive MD Announces Expansion into North Dakota and Utah
    Proactive MD Announces Expansion into North Dakota and Utah Business
  • War Day 163: war diaries w/Advisor to Ukraine President, Intel Officer @Alexey Arestovych  & #Feygin
    War Day 163: war diaries w/Advisor to Ukraine President, Intel Officer @Alexey Arestovych & #Feygin World News
  • Campus Resilience Program Releases New Exercise Starter Kits for Cybersecurity, Hurricanes, and Active Shooter Scenarios
    Campus Resilience Program Releases New Exercise Starter Kits for Cybersecurity, Hurricanes, and Active Shooter Scenarios World News
  • Kuwait National Day – United States Department of State
    Kuwait National Day – United States Department of State World News
  • Secretary Blinken’s Call with Azerbaijani President Aliyev
    Secretary Blinken’s Call with Azerbaijani President Aliyev World News
  • Metallic Powder Coating Global Market Set To Reach .38 Billion By 2028 At A CAGR Of 7.3%
    Metallic Powder Coating Global Market Set To Reach $2.38 Billion By 2028 At A CAGR Of 7.3% Business
  • Zack Viscomi Achieves Amazon Best-Seller Status with “Never Give Up,” Co-Authored with Dick Vitale
    Zack Viscomi Achieves Amazon Best-Seller Status with “Never Give Up,” Co-Authored with Dick Vitale Business
Envision Pharma Group Acquires OKRA.ai

Envision Pharma Group Acquires OKRA.ai

Posted on February 7, 2023 By NewsEditor
Envision Pharma Group Acquires OKRA.aiEnvision Pharma Group Acquires OKRA.aiPivotal acquisition in Envision Pharma Group's tech-enabled offerings provides clients with access to advanced AI to accelerate decision-making that optimizes their products' path to market and ultimately supports the delivery of enhanced patient outcomes.

PHILADELPHIA, February 7, 2023 (Newswire.com) - Envision Pharma Group (Envision), a leading global technology-enabled commercialization, integrated medical capabilities and solutions, and data analytics partner to the life sciences industry, announced today it has acquired OKRA.ai, an award-winning technology company active in the provision of artificial intelligence (AI) solutions with present brains across commercialization, real-world evidence and data analytics, medical, and pricing for the pharmaceutical and life sciences industry. 

OKRA.ai's AI products and solutions translate large clinical, scientific, and commercial data sets into actionable insights to empower decision-making and drive action to clients in the life sciences industry.

"We are delighted to welcome OKRA.ai into the Envision Pharma Group family," shares Meg Heim, CEO, Envision Pharma Group. "The acquisition of OKRA.ai marks an exciting milestone in Envision's evolution as we continue to accelerate and deliver a compelling combination of technology-enabled capabilities and solutions to clients. The combination of Envision's leading technology, capabilities, and solutions with OKRA.ai's artificial intelligence solutions and expertise enables us to strengthen our offerings to clients across the product life cycle, but more importantly, support patients in their journey to health and wellness."  

Dr. Loubna Bouarfa, founder of OKRA.ai, will be joining Envision as a member of its Executive Leadership Team. Recently, Loubna won the prestigious Deloitte Fast 50 Women in Leadership Award and Forbes 50 Top Women in Tech. Loubna shares, "Today is a redefining moment for OKRA.ai. I am honored to be joining forces with Envision and see enormous opportunities for the growth of our combined expertise and solutions for clients in the life sciences industry. As part of Envision Pharma Group, we can accelerate our work to bring AI to the heart of decision-making across the life sciences industry. Our success will not only bring commercial benefit to clients but lead to improved patient outcomes across the globe." 

Based in the U.K. and Netherlands, OKRA.ai employs around 30 members of staff. The acquisition of OKRA.ai will bring the total number of Envision Pharma Group to 1,400+ employees across four continents.  

About Envision Pharma Group
Founded in 2001, Envision Pharma Group is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies, including 18 of the top 20 pharmaceutical companies. Envision supports clients across the product lifecycle through a comprehensive suite of services and industry-leading technology solutions: including evidence-based scientific communications and engagement; commercialization and integrated medical consultancy; and HEOR/market access and data analytics capabilities. Learn more at www.envisionpharmagroup.com

About OKRA.ai 
OKRA.ai is a pioneer in developing AI solutions for the life sciences industry, bringing self-learning AI to optimize commercial, medical and market access decision making. Through its product portfolio, OKRA.ai delivers AI solutions to empower pharmaceutical companies with predictions and suggestions to bring novel treatments to patients in an efficient and effective way. 

OKRA.ai was founded by Dr. Loubna Bouarfa in 2015 with a vision of moving the healthcare industry towards data-driven decision-making by explainable AI. Since then, OKRA.ai has been instrumental in building industry-first Explainable AI which empowers users by providing explanations behind predictions and suggestions. OKRA.ai currently consists of a highly qualified workforce across the UK and the Netherlands and has a nearly equal gender balance (48% of staff are female). 

OKRA.ai's solution suite compiles healthcare data from multiple sources, with coverage across hundreds of therapeutic areas, thousands of clinical trials and publications, millions of medically relevant free text and billions of data points that are specific to patient demographics. Since 2015, OKRA.ai has supported the commercialization of 92 molecules, 67 indications and 13 pharmaceutical brands.

Contact Information:
Colleen Carter
Communications
[email protected]
1 (203) 480 0080


Original Source: Envision Pharma Group Acquires OKRA.ai Envision Pharma Group Acquires OKRA.ai
Business

Post navigation

Previous Post: Under Secretary Zeya’s Travel to Ulaanbaatar, Mongolia and Tokyo, Japan
Next Post: General Communication Equipment Market Size, Share And Growth Analysis For 2023-2032

Related Posts

  • Green Zen Office Plant Hire Launches in Dubai to Transform Workspaces and Events with Elegant Greenery
    Green Zen Office Plant Hire Launches in Dubai to Transform Workspaces and Events with Elegant Greenery Business
  • Zenon Energy has rebranded to Volstora to expand its market presence
    Zenon Energy has rebranded to Volstora to expand its market presence Business
  • Brian Hinman, a Founding CIPU Board Member, is Inducted into the IP Hall of Fame
    Brian Hinman, a Founding CIPU Board Member, is Inducted into the IP Hall of Fame Business
  • Polyphthalamide Resin Market Size, Share, Forecast, Trends And Overview For 2023-2032
    Polyphthalamide Resin Market Size, Share, Forecast, Trends And Overview For 2023-2032 Business
  • A2 Milk Market Size, Share, Revenue, Trends And Drivers For 2023-2032
    A2 Milk Market Size, Share, Revenue, Trends And Drivers For 2023-2032 Business
  • Demand for Long-term Birth Control Solutions Propel Growth
    Demand for Long-term Birth Control Solutions Propel Growth Business
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
« Jul    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • How the World’s Largest VLM System Powers Growth at Mouser ElectronicsAugust 27, 2025
  • NinjaTech AI Unveils World’s Fastest Deep Research: Revolutionizing AI-Powered Information AnalysisAugust 26, 2025
  • DSBS Changes Causing Confusion with Federal Contractors According to FEDCONAugust 26, 2025
  • Aircraft Band Clamps Market Size Expected to Reach $312 Million by 2031August 26, 2025
  • Javier Palomarez, USHBC President & CEO, Commends President Trump on Revocation of Biden-era Antitrust Executive OrderAugust 25, 2025
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • WAMC Reaches Its  Million Goal in One Morning
    WAMC Reaches Its $1 Million Goal in One Morning Business
  • TRIDENT Refit Facility Honored with 2024 Best of Georgia Award
    TRIDENT Refit Facility Honored with 2024 Best of Georgia Award Aviation
  • U.S.-India Civil Space Joint Working Group Advances Bilateral Space Collaboration
    U.S.-India Civil Space Joint Working Group Advances Bilateral Space Collaboration World News
  • War Day 303: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin
    War Day 303: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • Electric Aircraft Charging Interface Trends in Commercial, Defense & General Aviation | DataM Intelligence
    Electric Aircraft Charging Interface Trends in Commercial, Defense & General Aviation | DataM Intelligence Aviation
  • ZilBank.com’s Upgraded Features for US Account Opening, Virtual Card Management, and Seamless Money Transfers
    ZilBank.com’s Upgraded Features for US Account Opening, Virtual Card Management, and Seamless Money Transfers World News
  • FAA Urges Airlines, Pilots and Others to Take Key Safety Actions
    FAA Urges Airlines, Pilots and Others to Take Key Safety Actions Aviation
  • 5th ANNUAL DOULAGIVERS END OF LIFE FAMILY CAREGIVER “WORLD TRAINING DAY” ANNOUNCED
    5th ANNUAL DOULAGIVERS END OF LIFE FAMILY CAREGIVER “WORLD TRAINING DAY” ANNOUNCED World News
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195 News. All Rights Reserved by Coolaser | Partner of VUGA Enterprises |  Advertising: Get Published

Powered by .